|
Immunotherapy
Citations 171-180 of 577 total displayed.
|
Past content
(since Jun 2000):
|
Cytotoxic minor histocompatibility antigen HA-1–specific CD8+ effector memory T cells: artificial APCs pave the way for clinical application by potent primary in vitro induction
- Karin Schilbach, Gunter Kerst, Steffen Walter, Matthias Eyrich, Dorothee Wernet, Rupert Handgretinger, Weidong Xie, Hans-Georg Rammensee, Ingo Müller, Hans-Jörg Bühring, and Dietrich Niethammer
Blood 2005; 106: 144-149.
[Abstract]
[Full text]
[PDF]
A potential role for hydrocortisone in the positive regulation of IL-15–activated NK-cell proliferation and survival
- Sonia A. Perez, Louisa G. Mahaira, Fillio J. Demirtzoglou, Panagiota A. Sotiropoulou, Panayotis Ioannidis, Eleni G. Iliopoulou, Angelos D. Gritzapis, Nectaria N. Sotiriadou, Constantin N. Baxevanis, and Michael Papamichail
Blood 2005; 106: 158-166.
[Abstract]
[Full text]
[PDF]
The cancer-testis antigens CT7 (MAGE-C1) and MAGE-A3/6 are commonly expressed in multiple myeloma and correlate with plasma-cell proliferation
- Achim A. Jungbluth, Scott Ely, Maurizio DiLiberto, Ruben Niesvizky, Barbara Williamson, Denise Frosina, Yao-Tseng Chen, Nina Bhardwaj, Selina Chen-Kiang, Lloyd J. Old, and Hearn Jay Cho
Blood 2005; 106: 167-174.
[Abstract]
[Full text]
[PDF]
IFN- –mediated negative feedback regulation of NKT-cell function by CD94/NKG2
- Tsuyoshi Ota, Kazuyoshi Takeda, Hisaya Akiba, Yoshihiro Hayakawa, Kouetsu Ogasawara, Yoshinori Ikarashi, Sachiko Miyake, Hiro Wakasugi, Takashi Yamamura, Mitchell Kronenberg, David H. Raulet, Katsuyuki Kinoshita, Hideo Yagita, Mark J. Smyth, and Ko Okumura
Blood 2005; 106: 184-192.
[Abstract]
[Full text]
[PDF]
DC-NK cell cross talk as a novel CD4+ T-cell–independent pathway for antitumor CTL induction
- Christian Adam, Susan King, Thomas Allgeier, Heidi Braumüller, Carolin Lüking, Josef Mysliwietz, Anja Kriegeskorte, Dirk H. Busch, Martin Röcken, and Ralph Mocikat
Blood 2005; 106: 338-344.
[Abstract]
[Full text]
[PDF]
Genetic modification of primary natural killer cells overcomes inhibitory signals and induces specific killing of leukemic cells
- Chihaya Imai, Shotaro Iwamoto, and Dario Campana
Blood 2005; 106: 376-383.
[Abstract]
[Full text]
[PDF]
Assessment of treatment-related myelodysplastic syndromes and acute myeloid leukemia in patients with non-Hodgkin lymphoma treated with tositumomab and iodine I131 tositumomab
- John M. Bennett, Mark S. Kaminski, John P. Leonard, Julie M. Vose, Andrew D. Zelenetz, Susan J. Knox, Sandra Horning, Oliver W. Press, John A. Radford, Stewart M. Kroll, and Robert L. Capizzi
Blood 2005; 105: 4576-4582.
[Abstract]
[Full text]
[PDF]
Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells
- Manuela Battaglia, Angela Stabilini, and Maria-Grazia Roncarolo
Blood 2005; 105: 4743-4748.
[Abstract]
[Full text]
[PDF]
Induction of tolerance to factor VIII inhibitors by gene therapy with immunodominant A2 and C2 domains presented by B cells as Ig fusion proteins
- Tie Chi Lei and David W. Scott
Blood 2005; 105: 4865-4870.
[Abstract]
[Full text]
[PDF]
An inducible caspase 9 safety switch for T-cell therapy
- Karin C. Straathof, Martin A. Pulè, Patricia Yotnda, Gianpietro Dotti, Elio F. Vanin, Malcolm K. Brenner, Helen E. Heslop, David M. Spencer, and Cliona M. Rooney
Blood 2005; 105: 4247-4254.
[Abstract]
[Full text]
[PDF]
|
|
